nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextropropoxyphene—CYP3A7-CYP3A51P—Simvastatin—atherosclerosis	0.0675	0.0866	CbGbCtD
Dextropropoxyphene—CYP3A7—Simvastatin—atherosclerosis	0.0675	0.0866	CbGbCtD
Dextropropoxyphene—CYP3A7-CYP3A51P—Lovastatin—atherosclerosis	0.0661	0.0847	CbGbCtD
Dextropropoxyphene—CYP3A7—Lovastatin—atherosclerosis	0.0661	0.0847	CbGbCtD
Dextropropoxyphene—CYP2C8—Simvastatin—atherosclerosis	0.0487	0.0624	CbGbCtD
Dextropropoxyphene—CYP2C8—Lovastatin—atherosclerosis	0.0477	0.0611	CbGbCtD
Dextropropoxyphene—CYP2C8—Pravastatin—atherosclerosis	0.0477	0.0611	CbGbCtD
Dextropropoxyphene—CYP2D6—Niacin—atherosclerosis	0.0393	0.0504	CbGbCtD
Dextropropoxyphene—CYP2C9—Rosuvastatin—atherosclerosis	0.0365	0.0468	CbGbCtD
Dextropropoxyphene—CYP2C9—Simvastatin—atherosclerosis	0.034	0.0435	CbGbCtD
Dextropropoxyphene—CYP2C9—Lovastatin—atherosclerosis	0.0333	0.0426	CbGbCtD
Dextropropoxyphene—CYP2C9—Pravastatin—atherosclerosis	0.0333	0.0426	CbGbCtD
Dextropropoxyphene—CYP2D6—Simvastatin—atherosclerosis	0.0311	0.0398	CbGbCtD
Dextropropoxyphene—CYP2D6—Pravastatin—atherosclerosis	0.0304	0.039	CbGbCtD
Dextropropoxyphene—CYP2D6—Lovastatin—atherosclerosis	0.0304	0.039	CbGbCtD
Dextropropoxyphene—CYP3A4—Rosuvastatin—atherosclerosis	0.0213	0.0272	CbGbCtD
Dextropropoxyphene—CYP3A4—Ezetimibe—atherosclerosis	0.0213	0.0272	CbGbCtD
Dextropropoxyphene—CYP3A4—Simvastatin—atherosclerosis	0.0198	0.0253	CbGbCtD
Dextropropoxyphene—CYP3A4—Pravastatin—atherosclerosis	0.0193	0.0248	CbGbCtD
Dextropropoxyphene—CYP3A4—Lovastatin—atherosclerosis	0.0193	0.0248	CbGbCtD
Dextropropoxyphene—Myopathy—Rosuvastatin—atherosclerosis	0.00355	0.0251	CcSEcCtD
Dextropropoxyphene—Myopathy—Lovastatin—atherosclerosis	0.00301	0.0213	CcSEcCtD
Dextropropoxyphene—Myopathy—Ezetimibe—atherosclerosis	0.00295	0.0209	CcSEcCtD
Dextropropoxyphene—Myopathy—Simvastatin—atherosclerosis	0.00282	0.0199	CcSEcCtD
Dextropropoxyphene—Drug interaction—Rosuvastatin—atherosclerosis	0.00269	0.019	CcSEcCtD
Dextropropoxyphene—Myopathy—Niacin—atherosclerosis	0.00259	0.0183	CcSEcCtD
Dextropropoxyphene—Hepatomegaly—Niacin—atherosclerosis	0.00256	0.0181	CcSEcCtD
Dextropropoxyphene—Myopathy—Pravastatin—atherosclerosis	0.00255	0.018	CcSEcCtD
Dextropropoxyphene—Jaundice cholestatic—Lovastatin—atherosclerosis	0.0024	0.017	CcSEcCtD
Dextropropoxyphene—Jaundice cholestatic—Simvastatin—atherosclerosis	0.00225	0.0159	CcSEcCtD
Dextropropoxyphene—Drug interaction—Ezetimibe—atherosclerosis	0.00223	0.0158	CcSEcCtD
Dextropropoxyphene—Drug interaction—Simvastatin—atherosclerosis	0.00213	0.0151	CcSEcCtD
Dextropropoxyphene—Hepatocellular injury—Ezetimibe—atherosclerosis	0.00207	0.0147	CcSEcCtD
Dextropropoxyphene—Jaundice cholestatic—Niacin—atherosclerosis	0.00206	0.0146	CcSEcCtD
Dextropropoxyphene—Jaundice cholestatic—Pravastatin—atherosclerosis	0.00203	0.0144	CcSEcCtD
Dextropropoxyphene—Hepatocellular injury—Simvastatin—atherosclerosis	0.00197	0.014	CcSEcCtD
Dextropropoxyphene—Drug interaction—Pravastatin—atherosclerosis	0.00192	0.0136	CcSEcCtD
Dextropropoxyphene—Hepatocellular injury—Pravastatin—atherosclerosis	0.00179	0.0126	CcSEcCtD
Dextropropoxyphene—Hepatic function abnormal—Lovastatin—atherosclerosis	0.00175	0.0124	CcSEcCtD
Dextropropoxyphene—Hepatic function abnormal—Simvastatin—atherosclerosis	0.00164	0.0116	CcSEcCtD
Dextropropoxyphene—Hepatic function abnormal—Niacin—atherosclerosis	0.00151	0.0107	CcSEcCtD
Dextropropoxyphene—Hepatic function abnormal—Pravastatin—atherosclerosis	0.00148	0.0105	CcSEcCtD
Dextropropoxyphene—Liver function test abnormal—Ezetimibe—atherosclerosis	0.00139	0.00982	CcSEcCtD
Dextropropoxyphene—Jaundice—Rosuvastatin—atherosclerosis	0.00136	0.00961	CcSEcCtD
Dextropropoxyphene—Hepatobiliary disease—Rosuvastatin—atherosclerosis	0.00132	0.00933	CcSEcCtD
Dextropropoxyphene—Gastrointestinal haemorrhage—Niacin—atherosclerosis	0.00132	0.00932	CcSEcCtD
Dextropropoxyphene—Liver function test abnormal—Niacin—atherosclerosis	0.00122	0.0086	CcSEcCtD
Dextropropoxyphene—Liver function test abnormal—Pravastatin—atherosclerosis	0.0012	0.00847	CcSEcCtD
Dextropropoxyphene—Antazoline—HRH1—atherosclerosis	0.00113	0.153	CrCbGaD
Dextropropoxyphene—Jaundice—Ezetimibe—atherosclerosis	0.00113	0.00799	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Rosuvastatin—atherosclerosis	0.00112	0.00791	CcSEcCtD
Dextropropoxyphene—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.0011	0.00775	CcSEcCtD
Dextropropoxyphene—Jaundice—Simvastatin—atherosclerosis	0.00108	0.00762	CcSEcCtD
Dextropropoxyphene—Jaundice—Niacin—atherosclerosis	0.000989	0.007	CcSEcCtD
Dextropropoxyphene—Acute coronary syndrome—Pravastatin—atherosclerosis	0.000985	0.00697	CcSEcCtD
Dextropropoxyphene—Myocardial infarction—Pravastatin—atherosclerosis	0.000979	0.00693	CcSEcCtD
Dextropropoxyphene—Jaundice—Pravastatin—atherosclerosis	0.000973	0.00689	CcSEcCtD
Dextropropoxyphene—Pheniramine—HRH1—atherosclerosis	0.00094	0.127	CrCbGaD
Dextropropoxyphene—Immune system disorder—Ezetimibe—atherosclerosis	0.000939	0.00665	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Ezetimibe—atherosclerosis	0.000937	0.00663	CcSEcCtD
Dextropropoxyphene—Malnutrition—Ezetimibe—atherosclerosis	0.000905	0.00641	CcSEcCtD
Dextropropoxyphene—Confusional state—Rosuvastatin—atherosclerosis	0.000896	0.00634	CcSEcCtD
Dextropropoxyphene—Visual impairment—Niacin—atherosclerosis	0.000878	0.00621	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000872	0.00617	CcSEcCtD
Dextropropoxyphene—Vision blurred—Lovastatin—atherosclerosis	0.00087	0.00616	CcSEcCtD
Dextropropoxyphene—Visual impairment—Pravastatin—atherosclerosis	0.000864	0.00612	CcSEcCtD
Dextropropoxyphene—Clofedanol—HRH1—atherosclerosis	0.000856	0.116	CrCbGaD
Dextropropoxyphene—Eye disorder—Niacin—atherosclerosis	0.000851	0.00602	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Pravastatin—atherosclerosis	0.000832	0.00589	CcSEcCtD
Dextropropoxyphene—Vision blurred—Simvastatin—atherosclerosis	0.000814	0.00576	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Niacin—atherosclerosis	0.000813	0.00576	CcSEcCtD
Dextropropoxyphene—Insomnia—Rosuvastatin—atherosclerosis	0.000804	0.00569	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Pravastatin—atherosclerosis	0.000801	0.00567	CcSEcCtD
Dextropropoxyphene—Malnutrition—Niacin—atherosclerosis	0.000793	0.00561	CcSEcCtD
Dextropropoxyphene—Doxylamine—HRH1—atherosclerosis	0.000783	0.106	CrCbGaD
Dextropropoxyphene—Dyspepsia—Rosuvastatin—atherosclerosis	0.000782	0.00554	CcSEcCtD
Dextropropoxyphene—Discomfort—Lovastatin—atherosclerosis	0.000776	0.00549	CcSEcCtD
Dextropropoxyphene—Discomfort—Ezetimibe—atherosclerosis	0.000761	0.00539	CcSEcCtD
Dextropropoxyphene—Constipation—Rosuvastatin—atherosclerosis	0.00076	0.00538	CcSEcCtD
Dextropropoxyphene—Confusional state—Lovastatin—atherosclerosis	0.000759	0.00538	CcSEcCtD
Dextropropoxyphene—Vision blurred—Niacin—atherosclerosis	0.000747	0.00529	CcSEcCtD
Dextropropoxyphene—Confusional state—Ezetimibe—atherosclerosis	0.000745	0.00527	CcSEcCtD
Dextropropoxyphene—Tripelennamine—HRH1—atherosclerosis	0.000745	0.101	CrCbGaD
Dextropropoxyphene—Vision blurred—Pravastatin—atherosclerosis	0.000736	0.00521	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000732	0.00518	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000727	0.00514	CcSEcCtD
Dextropropoxyphene—Discomfort—Simvastatin—atherosclerosis	0.000726	0.00514	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Ezetimibe—atherosclerosis	0.000725	0.00513	CcSEcCtD
Dextropropoxyphene—Syncope—Niacin—atherosclerosis	0.000711	0.00503	CcSEcCtD
Dextropropoxyphene—Confusional state—Simvastatin—atherosclerosis	0.00071	0.00503	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Rosuvastatin—atherosclerosis	0.000703	0.00497	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Niacin—atherosclerosis	0.000697	0.00493	CcSEcCtD
Dextropropoxyphene—Insomnia—Lovastatin—atherosclerosis	0.000681	0.00482	CcSEcCtD
Dextropropoxyphene—Alimemazine—HRH1—atherosclerosis	0.000672	0.091	CrCbGaD
Dextropropoxyphene—Dyspnoea—Lovastatin—atherosclerosis	0.000672	0.00475	CcSEcCtD
Dextropropoxyphene—Insomnia—Ezetimibe—atherosclerosis	0.000668	0.00473	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Lovastatin—atherosclerosis	0.000663	0.00469	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Ezetimibe—atherosclerosis	0.000659	0.00466	CcSEcCtD
Dextropropoxyphene—Discomfort—Pravastatin—atherosclerosis	0.000656	0.00465	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000655	0.00463	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Ezetimibe—atherosclerosis	0.00065	0.0046	CcSEcCtD
Dextropropoxyphene—Constipation—Lovastatin—atherosclerosis	0.000644	0.00456	CcSEcCtD
Dextropropoxyphene—Confusional state—Pravastatin—atherosclerosis	0.000642	0.00455	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000638	0.00451	CcSEcCtD
Dextropropoxyphene—Asthenia—Rosuvastatin—atherosclerosis	0.000638	0.00451	CcSEcCtD
Dextropropoxyphene—Insomnia—Simvastatin—atherosclerosis	0.000637	0.00451	CcSEcCtD
Dextropropoxyphene—Shock—Niacin—atherosclerosis	0.000636	0.0045	CcSEcCtD
Dextropropoxyphene—Constipation—Ezetimibe—atherosclerosis	0.000632	0.00447	CcSEcCtD
Dextropropoxyphene—Tachycardia—Niacin—atherosclerosis	0.000631	0.00447	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Simvastatin—atherosclerosis	0.000628	0.00445	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Lovastatin—atherosclerosis	0.000621	0.00439	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Simvastatin—atherosclerosis	0.00062	0.00439	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000616	0.00436	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Ezetimibe—atherosclerosis	0.000609	0.00431	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000608	0.00431	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Rosuvastatin—atherosclerosis	0.000608	0.0043	CcSEcCtD
Dextropropoxyphene—Hypotension—Niacin—atherosclerosis	0.000605	0.00428	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000604	0.00428	CcSEcCtD
Dextropropoxyphene—Constipation—Simvastatin—atherosclerosis	0.000602	0.00426	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Lovastatin—atherosclerosis	0.000595	0.00421	CcSEcCtD
Dextropropoxyphene—Dizziness—Rosuvastatin—atherosclerosis	0.000588	0.00416	CcSEcCtD
Dextropropoxyphene—Insomnia—Niacin—atherosclerosis	0.000585	0.00414	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Ezetimibe—atherosclerosis	0.000584	0.00413	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Simvastatin—atherosclerosis	0.000581	0.00411	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Niacin—atherosclerosis	0.000577	0.00408	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000576	0.00408	CcSEcCtD
Dextropropoxyphene—Insomnia—Pravastatin—atherosclerosis	0.000576	0.00408	CcSEcCtD
Dextropropoxyphene—Somnolence—Niacin—atherosclerosis	0.000575	0.00407	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Niacin—atherosclerosis	0.000569	0.00403	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Pravastatin—atherosclerosis	0.000568	0.00402	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Pravastatin—atherosclerosis	0.000561	0.00397	CcSEcCtD
Dextropropoxyphene—Rash—Rosuvastatin—atherosclerosis	0.00056	0.00397	CcSEcCtD
Dextropropoxyphene—Dermatitis—Rosuvastatin—atherosclerosis	0.00056	0.00396	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Niacin—atherosclerosis	0.000559	0.00395	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Simvastatin—atherosclerosis	0.000557	0.00394	CcSEcCtD
Dextropropoxyphene—Headache—Rosuvastatin—atherosclerosis	0.000557	0.00394	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Lovastatin—atherosclerosis	0.000555	0.00393	CcSEcCtD
Dextropropoxyphene—Constipation—Pravastatin—atherosclerosis	0.000545	0.00386	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Ezetimibe—atherosclerosis	0.000544	0.00385	CcSEcCtD
Dextropropoxyphene—Asthenia—Lovastatin—atherosclerosis	0.00054	0.00382	CcSEcCtD
Dextropropoxyphene—Asthenia—Ezetimibe—atherosclerosis	0.00053	0.00375	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Niacin—atherosclerosis	0.000529	0.00374	CcSEcCtD
Dextropropoxyphene—Nausea—Rosuvastatin—atherosclerosis	0.000528	0.00374	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Pravastatin—atherosclerosis	0.000525	0.00372	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000521	0.00369	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Simvastatin—atherosclerosis	0.000519	0.00367	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Lovastatin—atherosclerosis	0.000515	0.00365	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Niacin—atherosclerosis	0.000511	0.00362	CcSEcCtD
Dextropropoxyphene—Asthenia—Simvastatin—atherosclerosis	0.000505	0.00358	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Ezetimibe—atherosclerosis	0.000505	0.00358	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Pravastatin—atherosclerosis	0.000504	0.00356	CcSEcCtD
Dextropropoxyphene—Dizziness—Lovastatin—atherosclerosis	0.000498	0.00353	CcSEcCtD
Dextropropoxyphene—Dizziness—Ezetimibe—atherosclerosis	0.000489	0.00346	CcSEcCtD
Dextropropoxyphene—Quinapril—ACE—atherosclerosis	0.000482	0.0654	CrCbGaD
Dextropropoxyphene—Diarrhoea—Simvastatin—atherosclerosis	0.000482	0.00341	CcSEcCtD
Dextropropoxyphene—Vomiting—Lovastatin—atherosclerosis	0.000479	0.00339	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Niacin—atherosclerosis	0.000477	0.00337	CcSEcCtD
Dextropropoxyphene—Rash—Lovastatin—atherosclerosis	0.000475	0.00336	CcSEcCtD
Dextropropoxyphene—Dermatitis—Lovastatin—atherosclerosis	0.000474	0.00336	CcSEcCtD
Dextropropoxyphene—Headache—Lovastatin—atherosclerosis	0.000472	0.00334	CcSEcCtD
Dextropropoxyphene—Vomiting—Ezetimibe—atherosclerosis	0.00047	0.00332	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Pravastatin—atherosclerosis	0.000469	0.00332	CcSEcCtD
Dextropropoxyphene—Dizziness—Simvastatin—atherosclerosis	0.000466	0.0033	CcSEcCtD
Dextropropoxyphene—Rash—Ezetimibe—atherosclerosis	0.000466	0.0033	CcSEcCtD
Dextropropoxyphene—Dermatitis—Ezetimibe—atherosclerosis	0.000465	0.00329	CcSEcCtD
Dextropropoxyphene—Asthenia—Niacin—atherosclerosis	0.000464	0.00329	CcSEcCtD
Dextropropoxyphene—Headache—Ezetimibe—atherosclerosis	0.000463	0.00328	CcSEcCtD
Dextropropoxyphene—Asthenia—Pravastatin—atherosclerosis	0.000457	0.00323	CcSEcCtD
Dextropropoxyphene—Vomiting—Simvastatin—atherosclerosis	0.000448	0.00317	CcSEcCtD
Dextropropoxyphene—Nausea—Lovastatin—atherosclerosis	0.000447	0.00317	CcSEcCtD
Dextropropoxyphene—Rash—Simvastatin—atherosclerosis	0.000444	0.00314	CcSEcCtD
Dextropropoxyphene—Dermatitis—Simvastatin—atherosclerosis	0.000444	0.00314	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Niacin—atherosclerosis	0.000443	0.00313	CcSEcCtD
Dextropropoxyphene—Headache—Simvastatin—atherosclerosis	0.000441	0.00312	CcSEcCtD
Dextropropoxyphene—Nausea—Ezetimibe—atherosclerosis	0.000439	0.00311	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Pravastatin—atherosclerosis	0.000436	0.00308	CcSEcCtD
Dextropropoxyphene—Dizziness—Niacin—atherosclerosis	0.000428	0.00303	CcSEcCtD
Dextropropoxyphene—Dizziness—Pravastatin—atherosclerosis	0.000421	0.00298	CcSEcCtD
Dextropropoxyphene—Nausea—Simvastatin—atherosclerosis	0.000418	0.00296	CcSEcCtD
Dextropropoxyphene—Vomiting—Niacin—atherosclerosis	0.000411	0.00291	CcSEcCtD
Dextropropoxyphene—Rash—Niacin—atherosclerosis	0.000408	0.00289	CcSEcCtD
Dextropropoxyphene—Dermatitis—Niacin—atherosclerosis	0.000408	0.00288	CcSEcCtD
Dextropropoxyphene—Headache—Niacin—atherosclerosis	0.000405	0.00287	CcSEcCtD
Dextropropoxyphene—Vomiting—Pravastatin—atherosclerosis	0.000405	0.00287	CcSEcCtD
Dextropropoxyphene—Rash—Pravastatin—atherosclerosis	0.000402	0.00284	CcSEcCtD
Dextropropoxyphene—Dermatitis—Pravastatin—atherosclerosis	0.000401	0.00284	CcSEcCtD
Dextropropoxyphene—Headache—Pravastatin—atherosclerosis	0.000399	0.00282	CcSEcCtD
Dextropropoxyphene—Nausea—Niacin—atherosclerosis	0.000384	0.00272	CcSEcCtD
Dextropropoxyphene—Nausea—Pravastatin—atherosclerosis	0.000378	0.00268	CcSEcCtD
Dextropropoxyphene—Toremifene—ESR1—atherosclerosis	0.000371	0.0503	CrCbGaD
Dextropropoxyphene—Trimipramine—HRH1—atherosclerosis	0.000299	0.0405	CrCbGaD
Dextropropoxyphene—Diphenhydramine—HRH1—atherosclerosis	0.000294	0.0398	CrCbGaD
Dextropropoxyphene—Orphenadrine—HRH1—atherosclerosis	0.000278	0.0377	CrCbGaD
Dextropropoxyphene—Tamoxifen—ESR2—atherosclerosis	0.000241	0.0326	CrCbGaD
Dextropropoxyphene—Tamoxifen—ESR1—atherosclerosis	0.000148	0.0201	CrCbGaD
Dextropropoxyphene—Phenylbutazone—PTGS2—atherosclerosis	0.00014	0.019	CrCbGaD
Dextropropoxyphene—CYP2C9—Metabolism—LPA—atherosclerosis	1.66e-05	0.000234	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—ESR1—atherosclerosis	1.66e-05	0.000234	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—IGF2—atherosclerosis	1.66e-05	0.000234	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—APOB—atherosclerosis	1.66e-05	0.000233	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—F2—atherosclerosis	1.64e-05	0.000231	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—NAMPT—atherosclerosis	1.63e-05	0.00023	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—BGN—atherosclerosis	1.63e-05	0.000229	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.63e-05	0.000229	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—LIPC—atherosclerosis	1.62e-05	0.000229	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—APOC3—atherosclerosis	1.61e-05	0.000227	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—GSTM1—atherosclerosis	1.61e-05	0.000227	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—APOB—atherosclerosis	1.61e-05	0.000227	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—BGN—atherosclerosis	1.61e-05	0.000227	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—APOA5—atherosclerosis	1.61e-05	0.000227	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—LDLR—atherosclerosis	1.6e-05	0.000226	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.6e-05	0.000225	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—CXCL8—atherosclerosis	1.6e-05	0.000225	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—PDGFB—atherosclerosis	1.6e-05	0.000225	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—APOA5—atherosclerosis	1.6e-05	0.000225	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—EDN1—atherosclerosis	1.59e-05	0.000223	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—LPL—atherosclerosis	1.58e-05	0.000223	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CCL5—atherosclerosis	1.57e-05	0.000222	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—PIK3CG—atherosclerosis	1.57e-05	0.000221	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—CETP—atherosclerosis	1.57e-05	0.000221	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—AGT—atherosclerosis	1.56e-05	0.000219	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.55e-05	0.000218	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	1.55e-05	0.000218	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—GPX1—atherosclerosis	1.54e-05	0.000217	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—LPL—atherosclerosis	1.54e-05	0.000217	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	1.54e-05	0.000216	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—LEP—atherosclerosis	1.53e-05	0.000215	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—APOE—atherosclerosis	1.53e-05	0.000215	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.52e-05	0.000214	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CAV1—atherosclerosis	1.51e-05	0.000213	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—APOA1—atherosclerosis	1.51e-05	0.000212	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—MAPK3—atherosclerosis	1.5e-05	0.000212	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.5e-05	0.000212	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—CD36—atherosclerosis	1.5e-05	0.000212	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.5e-05	0.000211	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—SCARB1—atherosclerosis	1.5e-05	0.000211	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—PRKCG—atherosclerosis	1.5e-05	0.000211	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—ALOX5—atherosclerosis	1.5e-05	0.000211	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—INS—atherosclerosis	1.49e-05	0.000209	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—ALOX5—atherosclerosis	1.48e-05	0.000209	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CCL2—atherosclerosis	1.46e-05	0.000206	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.46e-05	0.000206	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—SPP1—atherosclerosis	1.46e-05	0.000205	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—ESR1—atherosclerosis	1.46e-05	0.000205	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—CXCL8—atherosclerosis	1.45e-05	0.000204	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.45e-05	0.000204	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—F2—atherosclerosis	1.44e-05	0.000203	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—IGF1—atherosclerosis	1.44e-05	0.000202	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—MTHFR—atherosclerosis	1.43e-05	0.000201	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—HMGCR—atherosclerosis	1.42e-05	0.000199	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—PPARA—atherosclerosis	1.4e-05	0.000197	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—PIK3CG—atherosclerosis	1.38e-05	0.000194	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.37e-05	0.000193	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—SERPINE1—atherosclerosis	1.37e-05	0.000192	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—FABP4—atherosclerosis	1.36e-05	0.000192	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—LCAT—atherosclerosis	1.36e-05	0.000192	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—AGT—atherosclerosis	1.35e-05	0.000191	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—PDGFB—atherosclerosis	1.35e-05	0.00019	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—NAMPT—atherosclerosis	1.34e-05	0.000189	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—APOA4—atherosclerosis	1.34e-05	0.000188	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—LIPC—atherosclerosis	1.33e-05	0.000188	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—NAMPT—atherosclerosis	1.33e-05	0.000187	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—APOE—atherosclerosis	1.33e-05	0.000187	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—APOC3—atherosclerosis	1.33e-05	0.000187	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.32e-05	0.000186	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—LIPC—atherosclerosis	1.32e-05	0.000186	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—MAPK3—atherosclerosis	1.32e-05	0.000186	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—LDLR—atherosclerosis	1.32e-05	0.000185	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—AGT—atherosclerosis	1.32e-05	0.000185	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—CAV1—atherosclerosis	1.31e-05	0.000185	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—APOC3—atherosclerosis	1.31e-05	0.000185	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.31e-05	0.000185	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—APOA1—atherosclerosis	1.31e-05	0.000185	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—LDLR—atherosclerosis	1.31e-05	0.000184	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—NOS3—atherosclerosis	1.3e-05	0.000184	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—INS—atherosclerosis	1.3e-05	0.000184	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—LEP—atherosclerosis	1.29e-05	0.000182	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—APOE—atherosclerosis	1.29e-05	0.000182	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—CETP—atherosclerosis	1.29e-05	0.000181	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CCL2—atherosclerosis	1.28e-05	0.000181	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.28e-05	0.00018	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CAV1—atherosclerosis	1.28e-05	0.00018	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—CETP—atherosclerosis	1.28e-05	0.00018	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—APOA1—atherosclerosis	1.28e-05	0.00018	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—ABCA1—atherosclerosis	1.26e-05	0.000178	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—IGF1—atherosclerosis	1.26e-05	0.000178	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—SCARB1—atherosclerosis	1.23e-05	0.000173	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—ESR1—atherosclerosis	1.23e-05	0.000173	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—SCARB1—atherosclerosis	1.22e-05	0.000172	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—F2—atherosclerosis	1.22e-05	0.000171	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.21e-05	0.000171	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—SERPINE1—atherosclerosis	1.2e-05	0.000169	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—PIK3CG—atherosclerosis	1.2e-05	0.000169	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.19e-05	0.000167	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—PIK3CG—atherosclerosis	1.16e-05	0.000164	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—HMGCR—atherosclerosis	1.16e-05	0.000164	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CXCL8—atherosclerosis	1.16e-05	0.000163	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—PPARG—atherosclerosis	1.16e-05	0.000163	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—HMGCR—atherosclerosis	1.15e-05	0.000162	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.15e-05	0.000162	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.15e-05	0.000162	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—APOA2—atherosclerosis	1.15e-05	0.000162	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.15e-05	0.000162	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—NOS3—atherosclerosis	1.14e-05	0.000161	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.14e-05	0.00016	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—INS—atherosclerosis	1.13e-05	0.00016	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—AKT1—atherosclerosis	1.12e-05	0.000157	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—MAPK3—atherosclerosis	1.12e-05	0.000157	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—INS—atherosclerosis	1.1e-05	0.000155	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—IL6—atherosclerosis	1.1e-05	0.000155	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—LPA—atherosclerosis	1.1e-05	0.000154	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CCL2—atherosclerosis	1.08e-05	0.000153	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—HMOX1—atherosclerosis	1.08e-05	0.000153	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—IGF1—atherosclerosis	1.07e-05	0.00015	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—BGN—atherosclerosis	1.06e-05	0.00015	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—APOA5—atherosclerosis	1.05e-05	0.000148	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—MMP9—atherosclerosis	1.05e-05	0.000147	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.04e-05	0.000146	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—ALB—atherosclerosis	1.04e-05	0.000146	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—APOB—atherosclerosis	1.04e-05	0.000146	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—ABCA1—atherosclerosis	1.04e-05	0.000146	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—NFKB1—atherosclerosis	1.04e-05	0.000146	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—ABCA1—atherosclerosis	1.03e-05	0.000145	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—MAPK8—atherosclerosis	1.02e-05	0.000143	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—AKT1—atherosclerosis	1.02e-05	0.000143	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CXCL8—atherosclerosis	1.01e-05	0.000143	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1.01e-05	0.000143	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—SERPINE1—atherosclerosis	1.01e-05	0.000143	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—GSTM1—atherosclerosis	1.01e-05	0.000142	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—NOS3—atherosclerosis	9.94e-06	0.00014	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—LPL—atherosclerosis	9.91e-06	0.00014	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—AKT1—atherosclerosis	9.8e-06	0.000138	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ALOX5—atherosclerosis	9.78e-06	0.000138	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—GPX1—atherosclerosis	9.67e-06	0.000136	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—NOS3—atherosclerosis	9.67e-06	0.000136	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—IL6—atherosclerosis	9.65e-06	0.000136	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—CD36—atherosclerosis	9.42e-06	0.000133	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—VEGFA—atherosclerosis	9.4e-06	0.000132	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—STAT3—atherosclerosis	9.31e-06	0.000131	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—MMP9—atherosclerosis	9.18e-06	0.000129	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—PTGS2—atherosclerosis	9.09e-06	0.000128	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—NFKB1—atherosclerosis	9.08e-06	0.000128	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—MTHFR—atherosclerosis	8.93e-06	0.000126	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—MAPK8—atherosclerosis	8.92e-06	0.000126	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—AKT1—atherosclerosis	8.9e-06	0.000125	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—HMOX1—atherosclerosis	8.9e-06	0.000125	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—MAPK3—atherosclerosis	8.89e-06	0.000125	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—HMOX1—atherosclerosis	8.82e-06	0.000124	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—NAMPT—atherosclerosis	8.77e-06	0.000123	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PPARA—atherosclerosis	8.76e-06	0.000123	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—LIPC—atherosclerosis	8.72e-06	0.000123	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—APOC3—atherosclerosis	8.67e-06	0.000122	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—TGFB1—atherosclerosis	8.63e-06	0.000121	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—LDLR—atherosclerosis	8.61e-06	0.000121	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CXCL8—atherosclerosis	8.57e-06	0.000121	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—APOB—atherosclerosis	8.52e-06	0.00012	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—AGT—atherosclerosis	8.48e-06	0.000119	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—APOB—atherosclerosis	8.45e-06	0.000119	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CETP—atherosclerosis	8.41e-06	0.000118	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—APOE—atherosclerosis	8.31e-06	0.000117	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—GSTM1—atherosclerosis	8.29e-06	0.000117	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—AKT1—atherosclerosis	8.28e-06	0.000117	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—VEGFA—atherosclerosis	8.24e-06	0.000116	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—CAV1—atherosclerosis	8.23e-06	0.000116	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—GSTM1—atherosclerosis	8.22e-06	0.000116	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—APOA1—atherosclerosis	8.21e-06	0.000116	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—STAT3—atherosclerosis	8.16e-06	0.000115	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—IL6—atherosclerosis	8.15e-06	0.000115	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—LPL—atherosclerosis	8.14e-06	0.000115	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—LPL—atherosclerosis	8.07e-06	0.000114	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—SCARB1—atherosclerosis	8.06e-06	0.000113	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—GPX1—atherosclerosis	7.94e-06	0.000112	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—GPX1—atherosclerosis	7.87e-06	0.000111	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—MAPK3—atherosclerosis	7.8e-06	0.00011	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—MMP9—atherosclerosis	7.76e-06	0.000109	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—CD36—atherosclerosis	7.73e-06	0.000109	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—NFKB1—atherosclerosis	7.67e-06	0.000108	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—CD36—atherosclerosis	7.67e-06	0.000108	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—HMGCR—atherosclerosis	7.61e-06	0.000107	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—TGFB1—atherosclerosis	7.56e-06	0.000106	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—MAPK8—atherosclerosis	7.54e-06	0.000106	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—AKT1—atherosclerosis	7.52e-06	0.000106	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PIK3CG—atherosclerosis	7.5e-06	0.000106	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—MTHFR—atherosclerosis	7.33e-06	0.000103	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—MTHFR—atherosclerosis	7.26e-06	0.000102	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PPARG—atherosclerosis	7.24e-06	0.000102	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PPARA—atherosclerosis	7.19e-06	0.000101	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PPARA—atherosclerosis	7.13e-06	0.0001	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—INS—atherosclerosis	7.1e-06	9.99e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—VEGFA—atherosclerosis	6.96e-06	9.8e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—AGT—atherosclerosis	6.96e-06	9.8e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—AGT—atherosclerosis	6.9e-06	9.71e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—STAT3—atherosclerosis	6.9e-06	9.71e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—APOE—atherosclerosis	6.82e-06	9.6e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ABCA1—atherosclerosis	6.78e-06	9.54e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—APOE—atherosclerosis	6.76e-06	9.52e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—CAV1—atherosclerosis	6.76e-06	9.51e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—APOA1—atherosclerosis	6.74e-06	9.49e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—CAV1—atherosclerosis	6.7e-06	9.43e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—APOA1—atherosclerosis	6.69e-06	9.41e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—MAPK3—atherosclerosis	6.59e-06	9.27e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—ALB—atherosclerosis	6.51e-06	9.16e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—IL6—atherosclerosis	6.5e-06	9.15e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—TGFB1—atherosclerosis	6.39e-06	9e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—NOS3—atherosclerosis	6.23e-06	8.76e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PIK3CG—atherosclerosis	6.16e-06	8.66e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PIK3CG—atherosclerosis	6.1e-06	8.59e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—AKT1—atherosclerosis	6e-06	8.44e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PPARG—atherosclerosis	5.94e-06	8.36e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PPARG—atherosclerosis	5.89e-06	8.29e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—INS—atherosclerosis	5.83e-06	8.2e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—HMOX1—atherosclerosis	5.82e-06	8.19e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—INS—atherosclerosis	5.78e-06	8.13e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—IL6—atherosclerosis	5.7e-06	8.02e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PTGS2—atherosclerosis	5.69e-06	8.01e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—APOB—atherosclerosis	5.57e-06	7.84e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—GSTM1—atherosclerosis	5.42e-06	7.63e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—ALB—atherosclerosis	5.34e-06	7.52e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—LPL—atherosclerosis	5.32e-06	7.49e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—ALB—atherosclerosis	5.3e-06	7.45e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—AKT1—atherosclerosis	5.26e-06	7.4e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—GPX1—atherosclerosis	5.19e-06	7.31e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—NOS3—atherosclerosis	5.11e-06	7.19e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—NOS3—atherosclerosis	5.07e-06	7.13e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CD36—atherosclerosis	5.06e-06	7.12e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—IL6—atherosclerosis	4.82e-06	6.78e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—MTHFR—atherosclerosis	4.79e-06	6.74e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PPARA—atherosclerosis	4.7e-06	6.61e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PTGS2—atherosclerosis	4.67e-06	6.58e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PTGS2—atherosclerosis	4.63e-06	6.52e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—AKT1—atherosclerosis	4.57e-06	6.43e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—AGT—atherosclerosis	4.55e-06	6.41e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—APOE—atherosclerosis	4.46e-06	6.28e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—AKT1—atherosclerosis	4.44e-06	6.25e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CAV1—atherosclerosis	4.42e-06	6.22e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—APOA1—atherosclerosis	4.41e-06	6.21e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PIK3CG—atherosclerosis	4.03e-06	5.67e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PPARG—atherosclerosis	3.88e-06	5.47e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—INS—atherosclerosis	3.81e-06	5.36e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ALB—atherosclerosis	3.49e-06	4.92e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—NOS3—atherosclerosis	3.34e-06	4.7e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PTGS2—atherosclerosis	3.06e-06	4.3e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—AKT1—atherosclerosis	2.86e-06	4.03e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—AKT1—atherosclerosis	2.35e-06	3.31e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—AKT1—atherosclerosis	2.33e-06	3.28e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—AKT1—atherosclerosis	1.54e-06	2.16e-05	CbGpPWpGaD
